Skip to main content
Top
Published in: Obesity Surgery 6/2021

Open Access 01-06-2021 | Bariatric Surgery | Letter to the Editor

Immediate Euglycemic Diabetic Ketoacidosis After Gastric Bypass in a Patient with Type II Diabetes

Authors: Yu-Ting Lo, Kai-Hua Chen, Po-Chih Chang

Published in: Obesity Surgery | Issue 6/2021

Login to get access

Excerpt

Bariatric surgery has been proven to be an effective solution for morbid obesity with type 2 diabetes mellitus (T2DM), and such patients usually receive oral hypoglycemia agents or insulin for blood sugar control prior to surgery [1]. Though the occurrence of euglycemic diabetic ketoacidosis (DKA) is not clinically infrequent especially for those on treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitor, reports of DKA after bariatric surgery are limited and most of the available reports discussed type I diabetes [13]. …
Literature
1.
go back to reference Aminian A, Kashyap SR, Burguera B, et al. Incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care. 2016;39(4):e50–3.CrossRef Aminian A, Kashyap SR, Burguera B, et al. Incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care. 2016;39(4):e50–3.CrossRef
2.
go back to reference Rizo IM, Apovian CM. Diabetic ketoacidosis post bariatric surgery. Front Endocrinol (Lausanne). 2018;9:812.CrossRef Rizo IM, Apovian CM. Diabetic ketoacidosis post bariatric surgery. Front Endocrinol (Lausanne). 2018;9:812.CrossRef
3.
go back to reference Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. 2020 Apr 30. In: StatPearls. Treasure Island: StatPearls Publishing; 2020. Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. 2020 Apr 30. In: StatPearls. Treasure Island: StatPearls Publishing; 2020.
4.
go back to reference Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–93.CrossRef Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–93.CrossRef
5.
go back to reference Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638–42.CrossRef Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638–42.CrossRef
6.
go back to reference Burke KR, Schumacher CA, Harpe SE. SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017;37(2):187–94.CrossRef Burke KR, Schumacher CA, Harpe SE. SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017;37(2):187–94.CrossRef
7.
go back to reference Thiruvenkatarajan V, Meyer EJ, Nanjappa N, et al. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019;123(1):27–36.CrossRef Thiruvenkatarajan V, Meyer EJ, Nanjappa N, et al. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019;123(1):27–36.CrossRef
8.
go back to reference Hoenes C, Rashid Q, Pimentel J. Diabetic ketoacidosis in a postoperative gastric bypass patient. J Surg Case Rep. 2017;2017(7):rjx148.CrossRef Hoenes C, Rashid Q, Pimentel J. Diabetic ketoacidosis in a postoperative gastric bypass patient. J Surg Case Rep. 2017;2017(7):rjx148.CrossRef
9.
go back to reference Busetto L, Dicker D, Azran C, et al. Practical recommendations of the obesity management task force of the European Association for the study of obesity for the post-bariatric surgery medical management. Obes Facts. 2017;10(6):597–632.CrossRef Busetto L, Dicker D, Azran C, et al. Practical recommendations of the obesity management task force of the European Association for the study of obesity for the post-bariatric surgery medical management. Obes Facts. 2017;10(6):597–632.CrossRef
10.
go back to reference Mulla CM, Baloch HM, Hafida S. Management of diabetes in patients undergoing bariatric surgery. Curr Diab Rep. 2019;19(11):112.CrossRef Mulla CM, Baloch HM, Hafida S. Management of diabetes in patients undergoing bariatric surgery. Curr Diab Rep. 2019;19(11):112.CrossRef
11.
go back to reference Cipriano A, Rebelos E, Park N, et al. Moderate increase of serum levels of procalcitonin in diabetic ketoacidosis. Neth J Med. 2018;76(10):454.PubMed Cipriano A, Rebelos E, Park N, et al. Moderate increase of serum levels of procalcitonin in diabetic ketoacidosis. Neth J Med. 2018;76(10):454.PubMed
12.
go back to reference Zhang J, Zhao C, Wu T, et al. Procalcitonin may not be a differential diagnostic marker for bacterial infection in febrile patients with chronic gouty arthritis. J Int Med Res. 2018;46(10):4197–206.CrossRef Zhang J, Zhao C, Wu T, et al. Procalcitonin may not be a differential diagnostic marker for bacterial infection in febrile patients with chronic gouty arthritis. J Int Med Res. 2018;46(10):4197–206.CrossRef
13.
go back to reference Liu W, Sigdel KR, Wang Y, et al. High level serum procalcitonin associated gouty arthritis susceptibility: from a Southern Chinese Han population. PLoS One. 2015;10(7):e0132855.CrossRef Liu W, Sigdel KR, Wang Y, et al. High level serum procalcitonin associated gouty arthritis susceptibility: from a Southern Chinese Han population. PLoS One. 2015;10(7):e0132855.CrossRef
Metadata
Title
Immediate Euglycemic Diabetic Ketoacidosis After Gastric Bypass in a Patient with Type II Diabetes
Authors
Yu-Ting Lo
Kai-Hua Chen
Po-Chih Chang
Publication date
01-06-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05263-7

Other articles of this Issue 6/2021

Obesity Surgery 6/2021 Go to the issue